COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 1675: Articles 16741-16750  | Next

Exploring causal relationships between COVID-19 and cardiometabolic disorders: A bi-directional Mendelian randomization study
XIANG, Y., CHAU, C. K.-L., QIU, J., RAO, S., So, H.-C.
10.1101/2021.03.20.21254008 — Posted: 2021-03-20
Alternative splicing of OAS1 alters the risk for severe COVID-19
Huffman, J., Butler-Laporte, G., Khan, A., Drivas, T. G., Peloso, G. M., Nakanishi, T., Verma, A., Kiryluk, K., Richards, J. B., Zeberg, H.
10.1101/2021.03.20.21254005 — Posted: 2021-03-20
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
McGroder, C. F., Zhang, D., Choudhury, M. A., Salvatore, M. M., D'Souza, B. M., Hoffman, E. A., Wei, Y., Baldwin, M. R., Kim Garcia, C.
10.1101/2021.03.17.21253834 — Posted: 2021-03-20
COVID-19 Neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital
Thakur, K., Miller, E. H., Glendinning, M. D., Al Dalahmah, O., Banu, M., Boehme, A. K., Boubour, A., Bruce, S., Chong, A. M., Claassen, J., Faust, P., Hargus, G., Hickman, R., Jambawalikar, S., Khandji, A., Kim, C., Klein, R. S., Lignelli-Dipple, A., Lin, C.-C., Liu, Y., Miller, M., Moonis, G., Nordvig, A., Overdevest, J., Prust, M., Przedborski, S., Roth, W., Soung, A., Tanji, K., Teich, A., Agalliu, D., Uhlemann, A.-C., Goldman, J. E., Canoll, P.
10.1101/2021.03.16.21253167 — Posted: 2021-03-20
Serological response to COVID-19 vaccination in IBD patients receiving biologics
Wong, S.-Y., Dixon, R., Martinez Pazos, V., ICARUS-IBD, , Gnjatic, S., Colombel, J.-F., Cadwell, K.
10.1101/2021.03.17.21253848 — Posted: 2021-03-20
COVID-19 collateral damage: psychological distress and behavioral changes among older adults during the first outbreak in Stockholm, Sweden
Beridze, G., Triolo, F., Grande, G., Fratiglioni, L., Calderon-Larranaga, A.
10.1101/2021.03.16.21253750 — Posted: 2021-03-20
Generation of Inhibitory Autoantibodies to ADAMTS13 in Coronavirus Disease 2019
Doevelaar, A. A. N., Bachmann, M., Hoelzer, B., Seibert, F. S., Rohn, B. J., Witzke, O., Dittmer, U., Brenner, T., Paniskaki, K., Yilmaz, S., Dittmer, R., Schneppenheim, S., Babel, N., Budde, U., Westhoff, T. H.
10.1101/2021.03.18.21253869 — Posted: 2021-03-20
Diagnostic accuracy of rapid antigen tests in pre-/asymptomatic close contacts of individuals with a confirmed SARS-CoV-2 infection
Schuit, E., Veldhuijzen, I., Venekamp, R., Bijllaardt, W., Pas, S., Lodder, E., Molenkamp, R., GeurtsvanKessel, C., Velzing, J., Huisman, R., Brouwer, L., Boelsums, T., Sips, G., Benschop, K., Hooft, L., van de Wijgert, J., van den Hof, S., Moons, K.
10.1101/2021.03.18.21253874 — Posted: 2021-03-20 Discussion: Onsite
The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the Spike protein
Resende, P. C., Naveca, F. G., Lins, R. D., Dezordi, F. Z., Ferraz, M. V. F., Moreira, E. G., Coelho, D. F., Motta, F. C., Paixao, A. C. D., Appolinario, L., Lopes, R. S., Mendonca, A. C. d. F., da Rocha, A. S. B., Nascimento, V., Souza, V., Silva, G., Nascimento, F., Neto, L. G. L., Riediger, I., Debur, M. d. C., Leite, A. B., Mattos, T., da Costa, C. F., Pereira, F. M., Khouri, R., Bernardes, A. F. L., Delatorre, E., Graf, T., Siqueira, M. M., Bello, G., Wallau, G. L., Fiocruz COVID-19 Genomic Surveillance Network
10.1101/2021.03.19.21253946 — Posted: 2021-03-20
Predicting clinical outcomes in the Machine Learning era: The Piacenza score a purely data driven approach for mortality prediction in COVID-19 Pneumonia
halasz, g., Sperti, M., Villani, M., Michelucci, U., Agostoni, P., Biagi, A., Rossi, L., Botti, A., Mari, C., Maccarini, M., Pura, F., Roveda, L., nardecchia, a., Mottola, E., Nolli, M., salvioni, e., mapelli, m., deriu, M. A., Piga, D., Piepoli, M.
10.1101/2021.03.16.21253752 — Posted: 2021-03-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).